openPR Logo
Press release

Endometrial Cancer 2018 Global Market Key Players – Pfizer Inc., General Electric Company, Koninklijke Philips N.V., LUPIN, PHYTON, Bayer AG, Celgene Corporation, Johnson & Johnson – Analysis and Forecast to 2023

09-17-2018 10:53 AM CET | Health & Medicine

Press release from: Market Research Future

Endometrial Cancer 2018 Global Market Key Players – Pfizer

Market Research Future has declared the expansion of the "Worldwide Endometrial Cancer Market Research Report which gives Market Size, Shares and Forecasts till 2023.

Endometrial Cancer Market - Overview

The global endometrial cancer market is expecting a robust CAGR and a strong market presence during the forecast period (2018-2023), in an all-inclusive study asserts Market Research Future (MRFR).

Endometrial cancer is also known as uterine cancer and is the sixth most common cancer in women across the world. The daunting number speaks for itself and promotes the factors that ensure the market growth for endometrial cancer.

Get PDF with Technological Advancement @  https://www.marketresearchfuture.com/sample_request/6226

Endometrial Cancer Market -Drivers and Restraints

Urbanization across the world is experiencing an express speed growth rate owing to which the population is undergoing remarkable lifestyle change. A sedentary lifestyle has become the norm for many, and growing obesity among women is resulting in the rising number of endometrial cancer.

Lack of nutritional elements in consumed food and other diseases such as polycystic ovarian syndrome (PCOS) and the ovarian tumor can trigger endometrial cancer.

Endometrial Cancer Market -Dashboard

The market is witnessing significant funding going into research and developments. For instance, Salk Institutes is getting a sizeable amount of fund from Padres Pedal the Cause.

Others are mainly focusing on mergers and acquisitions. Royal Philips acquiring EPD Solutions can be taken exemplary. Boston Scientific has also acquired EMcision, Ltd.

The prominent players involved in the market are

Pfizer Inc.
General Electric Company
Koninklijke Philips N.V.
LUPIN
PHYTON
Bayer AG
Celgene Corporation
Johnson & Johnson
CooperSurgical Inc.
LiNA Medical USA
Conceptus Inc.
Hologic Inc.
Karl Storz GmbH & Co. Kg
Boston Scientific Corporation

Obtain Report Details with TOC @ https://www.marketresearchfuture.com/reports/endometrial-cancer-market-6226

Endometrial Cancer Market -Industry Trends

According to the Journal of Clinical Oncology, researchers of John Hopkins Medicine have found a new way to treat uterine cancer by adding the drug trastuzumab to the chemotherapy regimen of the uterine cancer patients.

PapSEEK is a type of liquid biopsy which is now enabling researchers to identify endometrial cancer at a very early stage. The screening procedure is still in its early stage, but it can surely benefit the doctors in diagnosing and treating their patients.

Endometrial Cancer Market -Segmentation

The global endometrial cancer market can be segmented by diagnosis, treatment, and end-user.By diagnosis, the market can further be segmented into the pelvic examination, transvaginal ultrasound, endometrial biopsy, dilation and curettage (D&C), and laparoscopy.

Treatment-based market includes hysterectomy techniques, radiation, hormone therapy, chemotherapy, and palliative care. Based on the end-users the market can be segmented into hospitals and clinics, ambulatory surgical centers, diagnostic centers, gynecology centers, feminist health centers, and others.

Endometrial Cancer Market -Regional Analysis

Region-wise the global endometrial cancer market covers the Americas, Europe, Asia-Pacific (APAC), and the Middle East and Africa (MEA).The Americas are currently holding the largest market share and can continue to do so in the near future.

The region has a well-structured healthcare system and extensive research units who are also contributing significantly to the regional market.

Europe is currently holding the second position in the market. Robust healthcare sector and advanced technologies are supporting the European market for uterine cancer treatment.The APAC can also witness significant growth in the market owing to rising incidence of cervical cancer in countries such as India and China.

For Exclusive Discount Visit @ https://www.marketresearchfuture.com/check-discount/6226

Some Points form Table of Content of Global Endometrial Cancer Market

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

..TOC Continued

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Endometrial Cancer 2018 Global Market Key Players – Pfizer Inc., General Electric Company, Koninklijke Philips N.V., LUPIN, PHYTON, Bayer AG, Celgene Corporation, Johnson & Johnson – Analysis and Forecast to 2023 here

News-ID: 1241726 • Views: 575

More Releases from Market Research Future

Autism Disorder and Treatment Market Pipeline Review and Industry Trend Analysis …
The global autism disorder and treatment market is expected to exhibit a CAGR of 4.37% over the forecast period from 2017 to 2023, according to a new report from Market Research Future (MRFR). The global autism disorder and treatment market was valued at USD 5,143.6 million in 2016 and is likely to exhibit rapid growth over the forecast period due to the rising awareness about autism spectrum disorders (ASD) and
Neurorehabilitation Devices Market Analysis By Top Companies : Hocoma AG, Ekso B …
Neurorehabilitation Devices Market Analysis The neurorehabilitation devices market is anticipated to touch USD 2.25 billion between 2013-2022, states the latest Market Research Future (MRFR) report. Neurorehabilitation devices are therapeutic devices that are utilized in rehabilitation programs. It deals with daunting challenges to learn to live with different neurological conditions including amyotrophic lateral sclerosis, peripheral nervous disorders, spinal cord injuries, brain tremor, multiple sclerosis, Parkinson's disease, epilepsy, ADHD, and Alzheimer's disease. Besides,
Microfluidics Devices Market Technology Improvements, Industry Share, Global Tre …
Detail Analysis of Global Microfluidics Devices Market with respect to region specific market growth and competitive analysis on the basis of major players present in the market. Detail analysis on possible segments and sub segments of the market. Along with this regional analysis of the market which includes America, Europe, Asia Pacific and Middle East and Africa. Forecast till 2023 The Microfluidics Devices Market is continually growing mainly due to the
Clear Aligners Market Size 2020, Share, Industry Growth, Global Analysis, Resear …
Global Clear Aligners Market Research Report: Information by Product Type (Hard, Medium and Soft), Age (Adult and Teenager), Distribution Channel (Direct Sales and Laboratories) and Region (Americas, Europe, Asia-Pacific and the Middle East & Africa) - Forecast till 2025 Clear Aligners Market Overview Global Clear Aligners Market size is expected to register 20.80% CAGR and is anticipated to reach USD 7019.96 Million by 2025, according to the latest market research report from

All 5 Releases


More Releases for Endometrial

Global Endometrial Ablation Market : Key Industry Developments
The presence of a number of large endometrial ablation enterprises such as Cooper Surgical Inc., Medtronic Plc, Boston Scientific Corp., Ethicon Inc., and Hologic Corp., has rendered the vendor landscape of the global endometrial ablation market highly competitive, observes Transparency Market Research in a recent report. To supersede competitors, companies in the market are focusing on growth strategies such as introduction of technologically advanced products and expansion across new regional
Endometrial Ablation Market - Global Industry Insights, 2025
Endometrial ablation is process that facilitates the destruction of endometrium or thin layer of the uterine wall, in context to treat abnormal heavy uterine bleeding if not controlled with any means of medication. Endometrial ablation is not recommended in women with disorders of endometrium, endometrial hyperplasia, cancer of uterus, recent pregnancy and certain infections of uterus, as per the American College of Obstetrics and Gynecology (ACOG). Depending on technique and
Endometrial Ablation Market - Global Industry Insights 2025
Endometrial ablation is process that facilitates the destruction of endometrium or thin layer of the uterine wall, in context to treat abnormal heavy uterine bleeding if not controlled with any means of medication. Endometrial ablation is not recommended in women with disorders of endometrium, endometrial hyperplasia, cancer of uterus, recent pregnancy and certain infections of uterus, as per the American College of Obstetrics and Gynecology (ACOG). Depending on technique and
Endometrial Biopsy Catheter Market Technological Breakthroughs
Perimenopausal and postmenopausal (absence of menstruation for 12 months or longer) women usually come across problems of abnormal uterine bleeding. Endometrial biopsy is a safe and efficient procedure for sampling the endometrium in a patient experiencing abnormal uterine bleeding to diagnose the condition and provide appropriate treatment. An endometrial suction catheter is used to carry out the biopsy. Endometrial biopsy catheters are easy to use, and have diagnostic accuracy which
Endometrial Ablation Market Growth Analysis 2024
TMR estimates that the global market for endometrial ablation will exhibit a promising CAGR of 5.50% from 2016 to 2024, rising from an opportunity worth US$0.8 bn in 2015 to US$1.3 bn by 2024. Rising Rate of Incidence of Gynecological Diseases to Drive Market The market is expected to benefit from a number of factors, which will be seen in its steady growth path over the course of the report’s forecast. The
Endometrial Ablation Market snapshot 2024
Global Endometrial Ablation Market: Snapshot With the rising prevalence of gynecology disorders, such as polycystic ovarian disease (PCOD), abnormal vaginal bleeding, the global adoption of endometrial ablation procedures has increased significantly, leading to an impressive rise in the worldwide endometrial ablation market. Apart from this, the upswing in the incidence rate of cervical and endometrial cancer in women is also driving the growth of this market substantially across the world. Download The